200670.KQ
Humedix Co., Ltd.
KOE · Healthcare · Drug Manufacturers - Specialty & Generic · KR
KRW 25,200.00
−2.14%Year over year
Reported trailing growth
- Revenue
- +12.6%
- EBITDA
- -30.2%
- EBIT
- -2.7%
- EPS
- -1.4%
- Free cash flow
- -45.0%
- Operating cash flow
- -23.3%
Forward estimates
Based on analyst estimates
- Revenue
- -40.5%
- EBITDA
- —
- EPS
- —
Three-year CAGR
- Revenue
- +11.3%
- EBITDA
- +2.8%
- EBIT
- +17.6%
- Net income
- +34.9%
- EPS
- +30.2%
- Free cash flow
- +6.4%
Reported trailing growth, forward expectations and three-year compound growth rates · Data as of Jun 1, 2026